Xiao-Yan Zhou

2.2k total citations
44 papers, 1.9k citations indexed

About

Xiao-Yan Zhou is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Xiao-Yan Zhou has authored 44 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 20 papers in Oncology and 17 papers in Pathology and Forensic Medicine. Recurrent topics in Xiao-Yan Zhou's work include Lymphoma Diagnosis and Treatment (10 papers), RNA modifications and cancer (8 papers) and Genetic factors in colorectal cancer (7 papers). Xiao-Yan Zhou is often cited by papers focused on Lymphoma Diagnosis and Treatment (10 papers), RNA modifications and cancer (8 papers) and Genetic factors in colorectal cancer (7 papers). Xiao-Yan Zhou collaborates with scholars based in China, United States and Netherlands. Xiao-Yan Zhou's co-authors include Xiang Du, Peng Qi, Mi‐die Xu, Shu-juan Ni, Cong Tan, Dan Huang, Meng-Hong Sun, Jing He, Li‐Xin Qiu and Abdül Waheed and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Clinical Cancer Research.

In The Last Decade

Xiao-Yan Zhou

44 papers receiving 1.9k citations

Peers

Countries citing papers authored by Xiao-Yan Zhou

Since Specialization

Citations

This map shows the geographic impact of Xiao-Yan Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiao-Yan Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiao-Yan Zhou more than expected).

Fields of papers citing papers by Xiao-Yan Zhou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiao-Yan Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiao-Yan Zhou. The network helps show where Xiao-Yan Zhou may publish in the future.

Co-authorship network of co-authors of Xiao-Yan Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Xiao-Yan Zhou. A scholar is included among the top collaborators of Xiao-Yan Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiao-Yan Zhou. Xiao-Yan Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Circulating long non-coding RNAs in cancer: current status and future perspectives 2016 ·Molecular Cancer ·Peng Qi, Xiao-Yan Zhou, Xiang Du	248
2	Primary Intestinal Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type: A Comprehensive Clinicopathological Analysis of 55 Cases 2016 ·PLoS ONE ·(unknown), (unknown), Wei-Qi Sheng, Chao‐Fu Wang, (unknown), Xiao-Yan Zhou, (unknown), (unknown)	20
3	Pituitary tumor-transforming gene-1 serves as an independent prognostic biomarker for gastric cancer 2015 ·Gastric Cancer ·Mi‐die Xu, Lei Dong, Peng Qi, (unknown), (unknown), Shu-juan Ni, Dan Huang, Cong Tan, Wei-Qi Sheng, Xiao-Yan Zhou, Xiang Du	28
4	Loss of B-cell Receptor Expression Defines a Subset of Diffuse Large B-cell Lymphoma Characterized by Silent BCR/PI3K/AKT Signaling and a Germinal Center Phenotype Displaying Low-risk Clinicopathologic Features 2015 ·The American Journal of Surgical Pathology ·(unknown), (unknown), Lei Wang, Zhu Fen, (unknown), Bo Ping, Xiao-Yan Zhou, (unknown)	12
5	Long Non-Coding RNA LSINCT5 Predicts Negative Prognosis and Exhibits Oncogenic Activity in Gastric Cancer 2014 ·Medicine ·Mi‐die Xu, Peng Qi, (unknown), (unknown), Shu-juan Ni, Lei Dong, Dan Huang, Cong Tan, Wei-Qi Sheng, Xiao-Yan Zhou, Xiang Du	55
6	Down‐regulation of ncRAN, a long non‐coding RNA, contributes to colorectal cancer cell migration and invasion and predicts poor overall survival for colorectal cancer patients 2014 ·Molecular Carcinogenesis ·Peng Qi, Mi‐die Xu, Shu-juan Ni, (unknown), Ping Wei, Dan Huang, Cong Tan, Wei-Qi Sheng, Xiao-Yan Zhou, Xiang Du	61
7	Association of LEP G2548A and LEPR Q223R Polymorphisms with Cancer Susceptibility: Evidence from a Meta-Analysis 2013 ·PLoS ONE ·Jing He, Bo Xi, Rikje Ruiter, Ting‐Yan Shi, Mei-Ling Zhu, Mengyun Wang, Qiao-Xin Li, Xiao-Yan Zhou, Li‐Xin Qiu, Qing-Yi Wei	26
8	Safety and efficacy of nimotuzumab in combination with radiotherapy for patients with squamous cell carcinoma of the esophagus 2013 ·International Journal of Clinical Oncology ·(unknown), (unknown), Xiaolong Fu, Yuan Li, Xiao-Yan Zhou, (unknown), Xi-Chun Hu, Min Fan, Jia-Qing Xiang, (unknown), Haiquan Chen, (unknown), Guo-Liang Jiang, Kuaile Zhao	29
9	A pri-miR-218variant and risk of cervical carcinoma in Chinese women 2013 ·BMC Cancer ·Tingyan Shi, Xiaojun Chen, Mei-Ling Zhu, Mengyun Wang, Jing He, Ke‐Da Yu, Zhi-Ming Shao, Meng-Hong Sun, Xiao-Yan Zhou, Xi Cheng, Xiaohua Wu, Qingyi Wei	38
10	Association of HER-2 Copy Number and HER-2/CEP-17 Ratio with Neoadjuvant Taxane-Containing Chemotherapy Sensitivity in Locally Advanced Breast Cancer 2012 ·The Oncologist ·Ke‐Da Yu, Guang‐Yu Liu, Xiao-Yan Zhou, Ying Zhou, Jiong Wu, (unknown), Zhen‐Zhou Shen, Zhi‐Ming Shao	7
11	RAD52 Variants Predict Platinum Resistance and Prognosis of Cervical Cancer 2012 ·PLoS ONE ·Tingyan Shi, Gong Yang, (unknown), (unknown), Ji Qian, (unknown), Xiao-Yan Zhou, Xi Cheng, Qingyi Wei	25
12	Crucial Involvement of Tumor-Associated Neutrophils in the Regulation of Chronic Colitis-Associated Carcinogenesis in Mice 2012 ·PLoS ONE ·Kun Shang, (unknown), Chen Wang, Zhen Wang, (unknown), Xiang Du, Xiao-Yan Zhou, (unknown), (unknown), Naofumi Mukaida, (unknown)	115
13	Association between XPF Polymorphisms and Cancer Risk: A Meta-Analysis 2012 ·PLoS ONE ·Ting‐Yan Shi, Jing He, Li‐Xin Qiu, Mei-Ling Zhu, Mengyun Wang, Xiao-Yan Zhou, Jiali Han, (unknown), Rongyu Zang, Qingyi Wei	30
14	Expression of follicular helper T cell markers in nodal peripheral T cell lymphomas: a tissue microarray analysis of 162 cases 2011 ·Journal of Clinical Pathology ·(unknown), (unknown), (unknown), (unknown), Xiao-Yan Zhou, Yan Chen	32
15	Prognostic value of carbonic anhydrase IX expression in penile squamous cell carcinoma: A pilot study 2011 ·Urologic Oncology Seminars and Original Investigations ·Yao Zhu, Xiao-Yan Zhou, Xu-Dong Yao, Shi-Lin Zhang, Bo Dai, Hai‐Liang Zhang, Yijun Shen, Ding-Wei Ye	4
16	Sox17 regulates proliferation and cell cycle during gastric cancer progression 2011 ·Cancer Letters ·(unknown), (unknown), (unknown), Ye Zhou, (unknown), (unknown), Xi Cao, Xiao-Yan Zhou, Meng-Hong Sun, (unknown)	50
17	FOXP1 expression and its clinicopathologic significance in nodal and extranodal diffuse large B-cell lymphoma 2010 ·Annals of Hematology ·(unknown), Xiao-Yan Zhou, (unknown), (unknown), (unknown), (unknown)	22
18	Molecular mechanisms of secondary imatinib resistance in patients with gastrointestinal stromal tumors 2009 ·Journal of Cancer Research and Clinical Oncology ·(unknown), Kai Huang, Ye Zhou, (unknown), (unknown), Hong Fu, Xiao-Yan Zhou, (unknown)	32
19	Lymphangiogenic and angiogenic microvessel density in human primary sporadic colorectal carcinoma 2008 ·World Journal of Gastroenterology ·Ge Yan, Xiao-Yan Zhou, San-Jun Cai, (unknown), (unknown), Du Xiang	32
20	Chromosomal Alteration in Chinese Sporadic Colorectal Carcinomas Detected by Comparative Genomic Hybridization 2007 ·Diagnostic Molecular Pathology ·(unknown), Xiao-Yan Zhou, (unknown), Meng-Hong Sun, Xiang Du	17

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact